Skip to main content
The Egyptian Heart Journal

Table 6 Correlation between QTc interval change and LV EF (%) after 6 months of S/V therapy

From: Unlocking the potential of sacubitril/valsartan therapy in improving ECG and echocardiographic parameters in heart failure patients with reduced ejection fraction (HErEF)

QTc interval (ms)

LV EF %

R

p-value

 

− 0.252*

0.012

  1. QTc interval, corrected QT interval; ms, millisecond
  2. *Spear Mann correlation coefficient
Back to article page